In hepatocellular carcinoma (HCC), sCLU is markedly overexpressed, contributing to resistance against oxaliplatin by downregulating Gadd45a expression and activating the PI3K/Akt pathway. The gene discussed is GADD45A; the disease is hepatocellular carcinoma.